Contained Microdosing Xcelodose® Technology

Delivering drug directly into capsules or vials using microdosing technology removes the need for initial formulation development and associated stability, leading to faster first-in-man studies and cost efficiencies.

The fully programmable system ensures exceptional levels of accuracy and precision whilst minimizing wastage of drug substance. We are proud to offer multiple options of microdosing technology, delivering individual client volume requirements.

PCI has further invested in Xcelohood™ and Xceloprotect™ technology for the microdosing technologies, further enhancing our contained solutions for the development and manufacturing of highly potent drug products.

Features of Xcelodose® Technology

Our dedicated team of specialists will be happy to discuss any of your Contained Microdosing Xcelodose® Technology needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com

Talk to us about our world leading contained microdosing services today.

talkfuture@pci.com

Always growing and continually advancing, we support you from early-stage development through commercialization and beyond, and with 6000+ people in 30 global GMP facilities, we are always near.